CPT 83916: Oligoclonal Band Assay, CSF with Serum

CPT code 83916 denotes an immunologic laboratory assay measuring oligoclonal bands in cerebrospinal fluid with a paired serum specimen. This test is clinically important for evaluating patients with suspected inflammatory central nervous system disorders, most notably multiple sclerosis, because the presence of CSF-restricted oligoclonal bands supports a diagnosis of intrathecal immunoglobulin production. Nationally, the test is performed in hospital and reference clinical laboratories and factors into diagnostic pathways for neurology and infectious disease evaluations.

Key payers in this analysis include Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare. Readers will find an overview of clinical context and typical sites of service, benchmarks and utilization patterns where available, and notes on common billing and coverage considerations for this laboratory procedure. The content clarifies what the code represents, why it matters to providers and payers, and what aspects of coding and service delivery are typically relevant for reimbursement and clinical documentation.

Data not available in the input includes specific payer policy details, associated taxonomies, related CPT or ICD-10 codes, and precise utilization benchmarks. The publication focuses on the clinical role of the assay and practical billing metadata for CPT code 83916 at a national level.

Billing Code Overview

CPT code 83916 measures oligoclonal immune bands in cerebrospinal fluid with a paired serum specimen. The test detects bands of immunoglobulins that are typically absent in normal spinal fluid and often present in patients with multiple sclerosis and other inflammatory central nervous system disorders.

Service type: Laboratory diagnostic immunologic assay
Typical site of service: Clinical laboratory or hospital laboratory performing cerebrospinal fluid and serum analysis

Clinical Context

A 34-year-old patient presents to neurology with subacute neurologic symptoms including numbness, visual disturbance, and gait instability. The neurologist suspects multiple sclerosis (MS) versus another inflammatory or infectious central nervous system (CNS) process. A lumbar puncture is performed in an outpatient clinic or hospital setting to obtain cerebrospinal fluid (CSF) and a paired serum specimen. The CSF and serum are sent to the clinical laboratory where the technologist performs oligoclonal band (OCB) analysis by isoelectric focusing and immunoblotting to detect intrathecal IgG synthesis. Results showing CSF-restricted oligoclonal bands support a diagnosis of MS or other CNS inflammatory disease, and are integrated with MRI findings, clinical exam, and other laboratory studies. Typical sites of service include hospital inpatient, hospital outpatient, or ambulatory specialty clinic with laboratory analysis performed in a certified clinical laboratory.

Coding Specifications

Modifier	Description	When to Use
`26`	Professional component	Use when only the professional interpretation component of the lab test is billed separately by a physician or pathologist.
`TC`	Technical component

Taxonomy Code	Specialty	Notes
207RP1000X	Neurology	Neurologists commonly order CSF OCB testing in evaluation of demyelinating disease.
207L00000X	Clinical Pathology	Pathologists/directors oversee laboratory immunologic testing and result interpretation.
261QM0800X	Clinical Laboratory Scientist	Laboratory professionals perform the technical OCB assay and reporting.
363L00000X	Hospital Laboratory	Institutional laboratories performing the technical component and specimen processing.
208000000X	Internal Medicine	Hospitalists or internists may order the test during inpatient evaluation.

Related Diagnoses

ICD-10 Code	Description	Clinical Relevance
`G35`	Multiple sclerosis	Primary indication for CSF oligoclonal band testing to detect intrathecal IgG synthesis supporting MS diagnosis.
`G04.89`	Other encephalitis and encephalopathy	OCB testing can help identify inflammatory CNS processes distinct from MS.
`G03.9`	Meningitis, unspecified	CSF analysis including OCBs may be performed when inflammatory or infectious meningitis is in differential.
`G37.9`	Demyelinating disease of central nervous system, unspecified	Used when demyelinating pathology is suspected and OCBs contribute to diagnostic evaluation.
`R20.2`	Paresthesia of skin	Symptom code often prompting neurologic workup including CSF studies when focal neurologic deficits are present.

Related CPT Codes

CPT Code	Description	Relationship to This Procedure
`83880`	Immunoelectrophoresis, protein electrophoresis interpretation and report	Performed as part of protein separation methods; sometimes used adjunctively to characterize CSF/serum immunoglobulins prior to oligoclonal band analysis.
`84156`	Protein; electrophoresis, serum (includes CSF protein electrophoresis when performed for diagnostic evaluation)	CSF total protein or CSF/serum protein electrophoresis often performed alongside OCB testing to assess blood–brain barrier function and protein abnormalities.
`36415`	Collection of venous blood by venipuncture	Used to obtain the paired serum specimen required for comparison with CSF in OCB testing.
`62270`	Spinal puncture, lumbar, diagnostic; with or without imaging guidance	Procedure code for CSF collection via lumbar puncture, which supplies the specimen for OCB analysis.
`84460`	Assay of immunoglobulin G (IgG)	Quantitative CSF and serum IgG measurements are commonly ordered with OCB testing to assess intrathecal IgG synthesis.

OpenPayer

Summary & Overview